Medicine and Dentistry
Levosimendan
100%
Kidney Injury
71%
Cisplatin
57%
Kidney Function
42%
Oral Drug Administration
28%
Endotoxemia
28%
Diabetic Nephropathy
28%
Arginine Methyl Ester
28%
Streptozocin
28%
Injection
28%
Kidney Blood Flow
28%
Reperfusion Injury
28%
Hypertension
28%
Inotropic Agent
28%
Nephrotoxicity
28%
Hypertensive Kidney Disease
28%
Kidney
28%
Pharmacology, Toxicology and Pharmaceutical Science
Levosimendan
100%
Kidney Injury
71%
Cisplatin
57%
Streptozotocin
28%
Reperfusion Injury
28%
Hypertension
28%
Inotropic Agent
28%
Endotoxemia
28%
Diabetic Nephropathy
28%
Experimental Animal
28%
Nephrotoxicity
28%
Sodium Chloride
28%
Arginine Methyl Ester
28%
Rat
14%